Trial	Phase	Sponsor	Dist.
Exploring Virtual Reality Adventure Training Exergaming	N/A	The University of Texas at Arlington	<1 mi
Effects of Exercise and Virtual Reality on Depression	N/A	The University of Texas at Arlington	<1 mi
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.	Phase 3	AbbVie	<1 mi
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder	Phase 3	Cybin IRL Limited	<1 mi
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms	Phase 3	Janssen Research & Development, LLC	<1 mi
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression	Phase 2	Draig Therapeutics Ltd	<1 mi
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	<1 mi
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)	Phase 2	atai Therapeutics, Inc.	<1 mi
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression	N/A	LivaNova	<1 mi
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms	Phase 4	Axsome Therapeutics, Inc.	<1 mi
Clinical Trial on Agitation in Alzheimer's Dementia	Phase 2	IGC Pharma, LLC	<1 mi
Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care	N/A	Elizabeth Arnold	<1 mi
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol	Phase 3	Axsome Therapeutics, Inc.	<1 mi
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients	Phase 3	Intra-Cellular Therapies, Inc.	<1 mi
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder	Phase 2	AbbVie	<1 mi
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder	Phase 2	AbbVie	<1 mi
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)	Phase 2	Tonix Pharmaceuticals, Inc.	<1 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses	Phase 2	Reunion Neuroscience Inc	<1 mi
Cancer Pain Management Using a Web-based Intervention	N/A	University of Texas at Austin	<1 mi
SAINT in Postpartum Depression (PPD)	N/A	Magnus Medical	<1 mi
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	<1 mi
Confirmatory Efficacy Trial of Attention Bias Modification for Depression	Early 1	University of Texas at Austin	<1 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)	Phase 3	Xenon Pharmaceuticals Inc.	<1 mi
Integrated Tele-Behavioral Activation and Fall Prevention for Low-income Homebound Seniors With Depression	N/A	University of Texas at Austin	<1 mi
Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression	Phase 4	University of Texas at Austin	<1 mi
To Improve Depressive Symptoms Using a Web-App	N/A	University of Texas at Austin	<1 mi
Accelerated Intermittent Theta Burst in Treatment-Naive Adolescents	N/A	University of Texas at Austin	<1 mi
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor	Phase 4	Neurocrine Biosciences	<1 mi
Psilocybin rTMS for Treatment Resistant Depression	Phase 2	University of Texas at Austin	<1 mi
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)	Phase 3	Definium Therapeutics US, Inc.	<1 mi
Parenting STAIR: Adapting a Trauma-Focused Parenting Intervention for Military-Connected Mothers and Their Children	N/A	New York University	<1 mi
Wellness App for Sleep Disturbance in Hematological Cancer Patients	N/A	The University of Texas Health Science Center at San Antonio	<1 mi
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)	Phase 2	Autobahn Therapeutics, Inc.	<1 mi
ALTO-207 in Adults With Treatment-resistant Depression (TRD)	Phase 2	Alto Neuroscience	<1 mi
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder	Phase 3	Intra-Cellular Therapies, Inc.	<1 mi
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	<1 mi
Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)	N/A	Baylor College of Medicine	<1 mi
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	<1 mi
MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression	N/A	VA Office of Research and Development	<1 mi
DBS for Depression	N/A	Baylor College of Medicine	<1 mi
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)	N/A	Abbott Medical Devices	<1 mi
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"	Phase 3	Cybin IRL Limited	<1 mi
Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer	Phase 2/3	M.D. Anderson Cancer Center	<1 mi
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response	Phase 2	ACADIA Pharmaceuticals Inc.	<1 mi
Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia	N/A	GrayMatters Health Ltd.	<1 mi
Telehealth Behavioral Activation for Teens	N/A	Baylor College of Medicine	<1 mi
Improving Adult Protective Services Client Outcomes: A Stepped-Care Social and Mental Health Engagement Program	N/A	The University of Texas Health Science Center, Houston	<1 mi
Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression	Phase 1	The University of Texas Health Science Center, Houston	<1 mi
Intracranial Investigation of Neural Circuity Underlying Human Mood	N/A	Baylor College of Medicine	<1 mi
Magnetic Seizure Therapy in Bipolar Depression (MST-BpD) and Treatment Resistant Depression (MST-TRD)	N/A	Joao L. DeQuevedo	<1 mi
Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality	Phase 2	The University of Texas Health Science Center, Houston	<1 mi
Improving Behavioral Health for Caregivers and Children After Pediatric Injury	N/A	Medical University of South Carolina	<1 mi
Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression	Phase 1	Texas A&M University	<1 mi
Deep Brain Stimulation of Treatment-Resistant Bipolar Depression	N/A	Wayne Goodman MD	<1 mi
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder	Phase 3	Janssen Research & Development, LLC	<1 mi
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users	N/A	Baylor College of Medicine	<1 mi
ALTO-100 in Bipolar Disorder With Depression (BD-D)	Phase 2	Alto Neuroscience	<1 mi
Developing Brain Imaging Analysis Expertise for Personalizing Transcranial Electric Stimulation in Anhedonia Treatment of Patients With Bipolar Depression	N/A	The University of Texas Health Science Center, Houston	<1 mi
Expansion and Evaluation of AI-generated Clinical Assessment (AI-COA®) of Depression and Anxiety Severity	N/A	Deliberate Solutions Inc.	<1 mi
Physiological and Psychological Effects of Music Therapy in the Pregnant Woman and Fetus	N/A	Christina Chianis Reed	<1 mi
Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia	N/A	The University of Texas Health Science Center, Houston	<1 mi
Transcutaneous Vagus Nerve Stimulation for Attention and Memory	N/A	Baylor College of Medicine	<1 mi
Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder	N/A	The University of Texas Health Science Center, Houston	<1 mi
Mapping and Modulating the Spatiotemporal Dynamics of Socio-Affective Processing	N/A	Baylor College of Medicine	<1 mi
Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy	Phase 2	M.D. Anderson Cancer Center	<1 mi
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors	Phase 2	M.D. Anderson Cancer Center	<1 mi
Neurodevelopmental Outcomes in Children: Strengthening the Caregiver-Child Story	—	Baylor College of Medicine	<1 mi
Behavioral Activation for the PreVention of Post-strokE Depression in LoW-incomE Older Stroke Survivors	N/A	The University of Texas Health Science Center, Houston	<1 mi
Leveraging Adult Protective Service Interaction to Offer Evidence-Based Treatment for Depression in Elder Neglect/Self Neglect	N/A	The University of Texas Health Science Center, Houston	<1 mi
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)	Phase 2	Seaport Therapeutics	<1 mi
Study of ALTO-300 in MDD	Phase 2	Alto Neuroscience	<1 mi
Combination of Novel Therapies for CKD Comorbid Depression	Phase 2	Stony Brook University	<1 mi
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services	—	Beth Israel Deaconess Medical Center	<1 mi
Preventing Vulnerable Child Syndrome in the NICU With Cognitive Behavioral Therapy (PreVNT Trial)	N/A	University of Texas Southwestern Medical Center	<1 mi
Recovery Through Inspiration, Support, and Empowerment	N/A	University of Texas Southwestern Medical Center	<1 mi
Tractography Guided Subcallosal Cingulate Deep Brain Stimulation for Treatment Resistant Depression	N/A	Nader Pouratian	<1 mi
Accelerated rTMS for Substance Use Disorder and Depression	N/A	University of Texas Southwestern Medical Center	<1 mi
Teen Recovery Through Inspiration, Support, and Empowerment	N/A	University of Texas Southwestern Medical Center	<1 mi
BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and Early Post-Childbirth Women	N/A	BTL Industries Ltd.	<1 mi
A Study of Brenipatide in Adult Participants With Major Depressive Disorder	Phase 3	Eli Lilly and Company	2 mi
Transcutaneous Auricular Neurostimulation (tAN) for Premenstrual Dysphoric Disorder (PMDD) and Perimenopause	N/A	Texas Christian University	2 mi
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma	N/A	Memorial Sloan Kettering Cancer Center	6 mi
rTMS for Military TBI-related Depression	N/A	Henry M. Jackson Foundation for the Advancement of Military Medicine	6 mi
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study	Phase 3	Yale University	7 mi
The OBSERVE Protocol	—	Yale University	7 mi
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.	Phase 2	LB Pharmaceuticals Inc.	13 mi
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder	Phase 3	Vanda Pharmaceuticals	13 mi
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	13 mi
Triage Survey for Psychiatry Research Eligibility	—	Adams Clinical	13 mi
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression	Phase 2	Draig Therapeutics Ltd	13 mi
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age	—	State University of New York at Buffalo	18 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder	Phase 3	Xenon Pharmaceuticals Inc.	18 mi
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)	Phase 3	Xenon Pharmaceuticals Inc.	20 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.